The study of Overexpression of Peroxiredoxin-2 Reduces MPP+-Induced Toxicity in SH-SY5Y Neuroblastoma Cells  

preprint OA: closed
View at publisher

Abstract

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by dopaminergic neuron loss. Excessive reactive oxygen species (ROS) accumulation has been implicated in the pathogenesis of Parkinson’s disease. Endogenous Peroxiredoxin-2 (Prdx-2) has potent anti-oxidative and anti-apoptotic effects. For further study of the activation of Prdx-2 and its role in vitro, SH-SY5Y cells were treated with MPP + or transfected with Prdx-2. The results showed that MPP + raises intracellular ROS, depolarizes mitochondrial membrane potential, decreases cell activity, and reduces expression of tyrosine hydroxylase (TH), Prdx-2, Silent Information Regulator of Transcription 1 (SIRT1), and increases the proapoptotic/anti-apoptotic expression ratio (Bax/Bcl2). When cells were transfected with Prdx-2, TH and SIRT1 were increased, the Bax/Bcl-2 ratio was decreased, ROS content was decreased, and cell activity was enhanced. However, this study not directly test whether Prdx-2 affects the downstream signaling factors of SIRT1.This will be the focus of the next stages of research.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00